Investigational Site Number 4501

Copenhagen 2100

0 studies enrolling now · 2 studies all time

What they study most

Hemophilia, Hemophilia A, Hemophilia B

Studies at this site

• A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis — Completed
• A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors — Completed